These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6229731)

  • 1. [Renal toxicity of 9-hydroxy-2-methylellipticinium].
    Ryckelynck JP; Heron JF; Juret P; De Ranieri E; Herlin P; Hardouin A; Le Talaer JY
    Presse Med; 1984 Jan; 13(2):104. PubMed ID: 6229731
    [No Abstract]   [Full Text] [Related]  

  • 2. [Renal toxicity of 9-hydroxy-2-methyl-ellipticinium].
    Ryckelynck JP; Heron JF; Juret P; Schneider P; Herlin P; De Ranieri E; Hardouin A; Peny J; Le Talaer JY
    Nephrologie; 1984; 5(2):59-63. PubMed ID: 6483073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Death during treatment with ellipticine].
    Grossman C; Cacoub P; Guillevin L; Royer I
    Ann Med Interne (Paris); 1985; 136(6):519. PubMed ID: 4083641
    [No Abstract]   [Full Text] [Related]  

  • 4. [Elliptinium acetate and the nephrotic syndrome].
    Pulik M; Dreyfus F; Varet B; Schneider P
    Nephrologie; 1986; 7(4):172-3. PubMed ID: 3796788
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fatal complication during treatment with elliptinium acetate].
    Pedinielli FJ; Routy JP; Blanc AP; Garrigues B
    Presse Med; 1985 Jan; 14(2):104. PubMed ID: 3156319
    [No Abstract]   [Full Text] [Related]  

  • 6. [N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)].
    Rouesse J; Tursz T; Le Chevalier T; Huertas D; Amiel JL; Brule G; Callet B; Droz JP; Voisin PM; Sancho-Garnier H; Le Pecq JB; Paoletti C
    Nouv Presse Med; 1981 May; 10(24):1997-9. PubMed ID: 7255136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of elliptinium in advanced renal cell carcinoma.
    Caillé P; Mondesir JM; Droz JP; Kerbrat P; Goodman A; Ducret JP; Theodore C; Spielman M; Rouëssé J; Amiel JL
    Cancer Treat Rep; 1985; 69(7-8):901-2. PubMed ID: 4016798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of elliptinium in advanced renal cell carcinoma and carcinoma of the breast.
    Sternberg CN; Yagoda A; Casper E; Scoppetuolo M; Scher HI
    Anticancer Res; 1985; 5(4):415-7. PubMed ID: 4037737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Kidney Injury and Renal Recovery with the Use of Aminoglycosides: A Large Retrospective Study.
    Paquette F; Bernier-Jean A; Brunette V; Ammann H; Lavergne V; Pichette V; Troyanov S; Bouchard J
    Nephron; 2015; 131(3):153-60. PubMed ID: 26389593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Failure of elliptinium acetate in the treatment of unresectable hepatocarcinoma (phase II trial)].
    Rougier P; Ychou M; Droz JP
    Bull Cancer; 1988; 75(10):979-81. PubMed ID: 2851337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal complications of anti-cancer treatments].
    Kessler M; Netter P
    Rev Med Interne; 1991; 12(5):369-73. PubMed ID: 1771317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Methyl-9-hydroxyellipticinium acetate (ellipticinium) in the treatment of lymphomas. Preliminary results of a phase II study.
    Tura S; Mandelli F; Mazza P; Cimino G; Anselmo AP; Amadori S
    Chemioterapia; 1984 Apr; 3(2):79-82. PubMed ID: 6532540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is nephrotoxicity of cyclosporine ineluctable?].
    Niaudet P
    Presse Med; 1994 Jun; 23(23):1061-3. PubMed ID: 7971816
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acute renal failure induced by antimicrobial and antineoplastic agents].
    Nakahama H; Fukuhara Y; Orita Y
    Nihon Rinsho; 1991 Jun; 49(6):1323-7. PubMed ID: 1886218
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute renal failure. 6. Renal failure caused by drugs or laboratory test procedures].
    Sakai O; OnoI
    Nihon Naika Gakkai Zasshi; 1993 Nov; 82(11):1807-11. PubMed ID: 8245608
    [No Abstract]   [Full Text] [Related]  

  • 16. Cisplatin-induced renal toxicity magn…ified: role of magnesium deficiency in AKI onset.
    Romani AM
    Am J Physiol Renal Physiol; 2015 Dec; 309(12):F1005-6. PubMed ID: 26511648
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute renal failure associated with gefitinib therapy.
    Wan HL; Yao NS
    Lung; 2006; 184(4):249-50. PubMed ID: 17006753
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine A and hypertension.
    Schachter M
    J Hypertens; 1988 Jul; 6(7):511-6. PubMed ID: 3049794
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective COX-2 inhibitors and nephrotoxicity.
    Balasubramaniam J
    Am J Kidney Dis; 2000 Sep; 36(3):675-6. PubMed ID: 10977804
    [No Abstract]   [Full Text] [Related]  

  • 20. Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy.
    Perazella MA; Moeckel GW
    Semin Nephrol; 2010 Nov; 30(6):570-81. PubMed ID: 21146122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.